Lloyd Thyro-Tab 0 — Class II drug recall D-439-2013
Terminated recall by Lloyd Inc. of Iowa, reported 2013-05-29, distributed nationwide. cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to de
| Recall number | D-439-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lloyd Inc. of Iowa, Shenandoah, IA, United States |
| Recall initiated | 2013-04-01 |
| Classified | 2013-05-21 |
| Reported by FDA | 2013-05-29 |
| Terminated | 2014-05-08 |
| Distributed | Nationwide (US) |
| Quantity | 7,614,709 tablets |
| Reason classes | cgmp, specification failure |
| Lot numbers | APR-13, AUG-13, HA04112, HC06212, HE27211, HE35511, JUL-13, SEP-12 |
Product
Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Reason for recall
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-439-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.